
Artificial pancreas app for type 1 diabetes patients launched after University of Cambridge research
An artificial pancreas app that enables insulin to be delivered automatically to people with type 1 diabetes was launched on Monday.
The world-first downloadable licensed app, CamAPS FX, follows 13 years of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.

It works with an insulin pump and a glucose monitor to deliver insulin via a complex algorithm.
Prof Hovorka, who hopes it will become available on the NHS in future, said: “This is a major stepping stone towards providing widely available, clinically proven, and user-friendly artificial pancreas technology to people with type 1 diabetes.
“Our aim is to alleviate the ever-present burden of type 1 diabetes and improve health outcomes. This is the outcome of hard work, with more to come. We are indebted to all who are helping us on this journey.”
Continue here –> cambridgeindependent.co.uk

